The present invention relates to hydrazone compounds of Formula I:
and pharmaceutically acceptable salts and stereoisomers thereof, wherein R
1
, R
2
, R
3
, R
4
, L
1
, and L
2
are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.
[EN] HYDRAZONE COMPOUNDS AND THEIR USE<br/>[FR] COMPOSÉS D'HYDRAZONE ET LEUR UTILISATION
申请人:STEIN PHILIP
公开号:WO2010132615A1
公开(公告)日:2010-11-18
The present invention relates to hydrazone compounds of Formula I: (I) and pharmaceutically acceptable salts and stereoisomers thereof, wherein R1, R2, R3, R4, L1, and L2 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I as inhibitors of TRPM5 protein.